BIOMAT Database Logo BIOMAT Database Logo

Vascular spasm during heparin-dihydroergotamine prophylaxis. 1987

R A Kilroy, and L D Aull, and L M Ellis
Department of Pharmacy Services, Shands Hospital, University of Florida, Gainesville 32610.

UI MeSH Term Description Entries
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D010689 Phlebitis Inflammation of a vein, often a vein in the leg. Phlebitis associated with a blood clot is called (THROMBOPHLEBITIS). Periphlebitis,Periphlebitides,Phlebitides
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D004087 Dihydroergotamine A 9,10alpha-dihydro derivative of ERGOTAMINE. It is used as a vasoconstrictor, specifically for the therapy of MIGRAINE DISORDERS. Agit,Angionorm,Clavigrenin,D-Tamin Retard L.U.T.,D.H.E. 45,DET MS,DHE-45,DHE-Puren,DHE-Ratiopharm,Dihydergot,Dihydroergotamin AL,Dihydroergotamine Mesylate,Dihydroergotamine Methanesulfonate,Dihydroergotamine-Sandoz,Dihytamin,Erganton,Ergomimet,Ergont,Ergotam Von Ct,Ikaran,Migranal,Orstanorm,Seglor,Tamik,Verladyn,D Tamin Retard L.U.T.,DHE 45,DHE Puren,DHE Ratiopharm,DHE45,Dihydroergotamine Sandoz,Mesylate, Dihydroergotamine,Methanesulfonate, Dihydroergotamine,Von Ct, Ergotam
D005260 Female Females
D005774 Gastrostomy Creation of an artificial external opening into the stomach for nutritional support or gastrointestinal compression. Gastrostomies
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D013035 Spasm An involuntary contraction of a muscle or group of muscles. Spasms may involve SKELETAL MUSCLE or SMOOTH MUSCLE. Muscle Spasm,Muscular Spasm,Spasm, Ciliary Body,Spasm, Generalized,Ciliary Body Spasm,Ciliary Body Spasms,Generalized Spasm,Generalized Spasms,Muscle Spasms,Muscular Spasms,Spasm, Muscle,Spasm, Muscular,Spasms,Spasms, Ciliary Body,Spasms, Generalized,Spasms, Muscle,Spasms, Muscular

Related Publications

R A Kilroy, and L D Aull, and L M Ellis
Vascular spasm during thromboembolism prophylaxis with heparin-dihydroergotamine.
July 1982, Lancet (London, England),
R A Kilroy, and L D Aull, and L M Ellis
Vascular spasm and gangrene during heparin-dihydro-ergotamine prophylaxis.
November 1984, The British journal of surgery,
R A Kilroy, and L D Aull, and L M Ellis
Skin and muscle necrosis during heparin-dihydroergotamine prophylaxis.
October 1984, Lancet (London, England),
R A Kilroy, and L D Aull, and L M Ellis
Ergotism and heparin-dihydroergotamine prophylaxis.
June 1982, Lancet (London, England),
R A Kilroy, and L D Aull, and L M Ellis
Risk/benefit of heparin-dihydroergotamine thromboembolic prophylaxis.
January 1986, Lancet (London, England),
R A Kilroy, and L D Aull, and L M Ellis
[Complications of thromboembolic prophylaxis with heparin-dihydroergotamine].
May 1989, Agressologie: revue internationale de physio-biologie et de pharmacologie appliquees aux effets de l'agression,
R A Kilroy, and L D Aull, and L M Ellis
Dihydroergotamine-heparin prophylaxis of postoperative deep vein thrombosis.
February 1985, JAMA,
R A Kilroy, and L D Aull, and L M Ellis
Prophylaxis of postoperative thromboembolism: low dose heparin versus heparin plus dihydroergotamine.
February 1983, Thrombosis research,
R A Kilroy, and L D Aull, and L M Ellis
[Severe arterial spasm in a patient after treatment with dihydroergotamine heparin].
March 1986, Lakartidningen,
R A Kilroy, and L D Aull, and L M Ellis
Ergotism as complication of thromboembolic prophylaxis with heparin-dihydroergotamine.
January 1987, Lancet (London, England),
Copied contents to your clipboard!